The Neuroendocrine Unit at the Massachusetts General Hospital (MGH) in
Boston are investigating whether testosterone replacement therapy will
improve bone density, mood, sex drive, well-being and the amount of body
fat and muscle in women with hypopituitarism. Qualifying patients will
be seen at the hospital six times over the 12-month study period.
Remuneration up to $600 is offered, as is reimbursement for travel to
Boston. For information, contact Dr. Karen Miller at (617) 724-7388 or
by e-mail at kkmiller@partners.org.
Women with a history of pituitary problems are at increased risk for bone
loss, obesity, dimiinished libido, and a decreased quality of life.
Researchers at the Massachusetts General Hospital are studying causes and
possible natural hormonal treatments for these problems. Women between the
ages of 18 and 50 who are interested in finding out about a year-long
research study may contact Dr. Karen Miller at (617) 724-7388
(kkmiller@partners.org). A stipend
of up to $600 is available to those who qualify.
Women ages 18 to 65 with growth hormone deficiency may be eligible to participate
in a study of the impact of growth hormone replacement upon cardiovascular
parameters. Participation requires 12 visits over a a 12-month period.
Compensation up to $300 is provided. For information, call Karen Visnaw, RN, at
(617) 726-0972, Neuroendocrine Unit, MGH.
Read about events on Capitol Hill, funding for rare-disease research, and other topics of interest from NORD's office in Washington, DC.
